Three-dimensional–cultured renal tubular model reveals FXR-HNF4α-OAT1/3 axis as a target for preventing nucleotide analog–induced kidney injury
Drug Metabolism and Disposition · 2026
DOI: 10.1016/j.dmd.2025.100214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026. Verfasst von Itsuki Yokoseki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 4, Organic Anion Transport Protein 1, Receptors, Cytoplasmic and Nuclear, Kidney Tubules, Proximal. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Government of Japan Ministry of Education Culture Sports Science and Technology, Japan Science and Technology Agency, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Drug-induced kidney injury, often resulting from the intracellular accumulation of drugs in renal proximal tubule cells via uptake transporters such as organic anion transporters 1 and 3 (OAT1/3), remains a major obstacle in drug development. Conventional 2-dimensional cultures of human renal proximal tubule epithelial cells (RPTECs) hardly express OAT1/3, limiting their utility for toxicity assessment. In contrast, 3-dimensional (3D) cultures of RPTEC have been shown to markedly upregulate OAT1/3 expression, offering a more physiologically relevant in vitro model for evaluating the toxicity of anionic compounds. In this study, we investigated the mechanism underlying OAT1/3 upregulation in 3D-RPTEC and explored a strategy to mitigate transporter-mediated toxicity. We found that hepatocyte nuclear factor (HNF) 4α expression is also increased in 3D-RPTEC. Motif analysis and cleavage under targets and release using nuclease-quantitative polymerase chain reaction revealed that HNF4α directly binds to the promoters of SLC22A6 and SLC22A8, identifying it as a key transcriptional regulator of OAT1/3 expression. Activation of the farnesoid X receptor (FXR), which represses the binding of HNF4α to promoters through the upregulation of small heterodimer partner (SHP), decreased OAT1/3 expression. Treatment with FXR ligands reduced cellular uptake of OAT1/3 substrates (eg, tenofovir and adefovir) and decreased their cytotoxic effects in 3D-RPTEC. These findings elucidate a transcriptional mechanism by which HNF4α regulates OAT1/3 expression in 3D-RPTEC and demonstrate that FXR agonists can downregulate OAT1/3 expression via the HNF4α-SHP axis. The present study highlights the utility of 3D-RPTEC as a valuable platform for mechanistic studies of transporter regulation. SIGNIFICANCE STATEMENT: This study shows that farnesoid X receptor agonists suppress hepatocyte nuclear factor 4α-mediated OAT1/3 activity in 3-dimensional-cultured renal proximal tubular cells and reduce nucleotide analog-induced toxicity. These findings provide mechanistic insight into transporter regulation and suggest a potential strategy to prevent nephrotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan.
- Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-NanoLSI) Kanazawa University, Kanazawa, Japan. Electronic address: mnakano@p…
- Bio Business Promotion Department, Medical Division, Nikkiso Co. Ltd., Kanazawa, Japan.
- Global Clinical Pharmacology & Non-clinical Safety Science, DMPK, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
- Pharmaceutical and Health Sciences, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan; Department of Regulatory Science, Nagoya City University Graduate School of Pharmaceutical Sciences, Nagoya,…
- Membrane Transport and Biopharmaceutics, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan.
Förderung
- Government of Japan Ministry of Education Culture Sports Science and Technology
- Japan Science and Technology Agency
- Japan Agency for Medical Research and Development
Zitieren
APA
Yokoseki, I., Nakano, M., Takahashi, E., Morimura, K., Nishioka, Y., Araki, A., Jimbo, Y., Ishiguro, N., Arawaka, H., Tamai, I., Fukami, T., & Nakajima, M. (2026). Three-dimensional–cultured renal tubular model reveals FXR-HNF4α-OAT1/3 axis as a target for preventing nucleotide analog–induced kidney injury. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100214
Vancouver
Yokoseki I, Nakano M, Takahashi E, Morimura K, Nishioka Y, Araki A, et al. Three-dimensional–cultured renal tubular model reveals FXR-HNF4α-OAT1/3 axis as a target for preventing nucleotide analog–induced kidney injury. Drug Metabolism and Disposition. 2026. doi:10.1016/j.dmd.2025.100214
BibTeX
@article{Yokoseki2026,
author = {Yokoseki, Itsuki and Nakano, Masataka and Takahashi, Etsushi and Morimura, Kaoru and Nishioka, Yukiko and Araki, Ayano and Jimbo, Yoichi and Ishiguro, Naoki and Arawaka, Hiroshi and Tamai, Ikumi and Fukami, Tatsuki and Nakajima, Miki},
title = {Three-dimensional–cultured renal tubular model reveals FXR-HNF4α-OAT1/3 axis as a target for preventing nucleotide analog–induced kidney injury},
journal = {Drug Metabolism and Disposition},
year = {2026},
doi = {10.1016/j.dmd.2025.100214}
}
EUVIMED